Global Theraputic Drug Monitorings Market Size, Status and Forecast 2024-2031

Report ID: 920532 | Published Date: Nov 2024 | No. of Page: 126 | Base Year: 2023 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Theraputic Drug Monitorings Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Chemiluminescence Immunoassay (CLIA)
        1.2.3 Fluorescence Immunoassay (FPIA)
        1.2.4 Radioimmunoassay (RIA)
        1.2.5 Colorimetric Immunoassay
        1.2.6 Other Immunoassays
    1.3 Market by Application
        1.3.1 Global Theraputic Drug Monitorings Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Antiepileptic Drugs
        1.3.3 Immunosuppressant
        1.3.4 Antitumor Drugs
        1.3.5 Psychotropic Drugs
        1.3.6 Antibiotic
        1.3.7 Antifungal
        1.3.8 Cardiovascular Drugs
        1.3.9 Antiasthmatic
        1.3.10 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Theraputic Drug Monitorings Market Perspective (2016-2027)
    2.2 Theraputic Drug Monitorings Growth Trends by Regions
        2.2.1 Theraputic Drug Monitorings Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Theraputic Drug Monitorings Historic Market Share by Regions (2016-2021)
        2.2.3 Theraputic Drug Monitorings Forecasted Market Size by Regions (2022-2027)
    2.3 Theraputic Drug Monitorings Industry Dynamic
        2.3.1 Theraputic Drug Monitorings Market Trends
        2.3.2 Theraputic Drug Monitorings Market Drivers
        2.3.3 Theraputic Drug Monitorings Market Challenges
        2.3.4 Theraputic Drug Monitorings Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Theraputic Drug Monitorings Players by Revenue
        3.1.1 Global Top Theraputic Drug Monitorings Players by Revenue (2016-2021)
        3.1.2 Global Theraputic Drug Monitorings Revenue Market Share by Players (2016-2021)
    3.2 Global Theraputic Drug Monitorings Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Theraputic Drug Monitorings Revenue
    3.4 Global Theraputic Drug Monitorings Market Concentration Ratio
        3.4.1 Global Theraputic Drug Monitorings Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Theraputic Drug Monitorings Revenue in 2020
    3.5 Theraputic Drug Monitorings Key Players Head office and Area Served
    3.6 Key Players Theraputic Drug Monitorings Product Solution and Service
    3.7 Date of Enter into Theraputic Drug Monitorings Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Theraputic Drug Monitorings Breakdown Data by Type
    4.1 Global Theraputic Drug Monitorings Historic Market Size by Type (2016-2021)
    4.2 Global Theraputic Drug Monitorings Forecasted Market Size by Type (2022-2027)

5 Theraputic Drug Monitorings Breakdown Data by Application
    5.1 Global Theraputic Drug Monitorings Historic Market Size by Application (2016-2021)
    5.2 Global Theraputic Drug Monitorings Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Theraputic Drug Monitorings Market Size (2016-2027)
    6.2 North America Theraputic Drug Monitorings Market Size by Type
        6.2.1 North America Theraputic Drug Monitorings Market Size by Type (2016-2021)
        6.2.2 North America Theraputic Drug Monitorings Market Size by Type (2022-2027)
        6.2.3 North America Theraputic Drug Monitorings Market Size by Type (2016-2027)
    6.3 North America Theraputic Drug Monitorings Market Size by Application
        6.3.1 North America Theraputic Drug Monitorings Market Size by Application (2016-2021)
        6.3.2 North America Theraputic Drug Monitorings Market Size by Application (2022-2027)
        6.3.3 North America Theraputic Drug Monitorings Market Size by Application (2016-2027)
    6.4 North America Theraputic Drug Monitorings Market Size by Country
        6.4.1 North America Theraputic Drug Monitorings Market Size by Country (2016-2021)
        6.4.2 North America Theraputic Drug Monitorings Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Theraputic Drug Monitorings Market Size (2016-2027)
    7.2 Europe Theraputic Drug Monitorings Market Size by Type
        7.2.1 Europe Theraputic Drug Monitorings Market Size by Type (2016-2021)
        7.2.2 Europe Theraputic Drug Monitorings Market Size by Type (2022-2027)
        7.2.3 Europe Theraputic Drug Monitorings Market Size by Type (2016-2027)
    7.3 Europe Theraputic Drug Monitorings Market Size by Application
        7.3.1 Europe Theraputic Drug Monitorings Market Size by Application (2016-2021)
        7.3.2 Europe Theraputic Drug Monitorings Market Size by Application (2022-2027)
        7.3.3 Europe Theraputic Drug Monitorings Market Size by Application (2016-2027)
    7.4 Europe Theraputic Drug Monitorings Market Size by Country
        7.4.1 Europe Theraputic Drug Monitorings Market Size by Country (2016-2021)
        7.4.2 Europe Theraputic Drug Monitorings Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Theraputic Drug Monitorings Market Size (2016-2027)
    8.2 Asia-Pacific Theraputic Drug Monitorings Market Size by Type
        8.2.1 Asia-Pacific Theraputic Drug Monitorings Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Theraputic Drug Monitorings Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Theraputic Drug Monitorings Market Size by Type (2016-2027)
    8.3 Asia-Pacific Theraputic Drug Monitorings Market Size by Application
        8.3.1 Asia-Pacific Theraputic Drug Monitorings Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Theraputic Drug Monitorings Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Theraputic Drug Monitorings Market Size by Application (2016-2027)
    8.4 Asia-Pacific Theraputic Drug Monitorings Market Size by Region
        8.4.1 Asia-Pacific Theraputic Drug Monitorings Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Theraputic Drug Monitorings Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Theraputic Drug Monitorings Market Size (2016-2027)
    9.2 Latin America Theraputic Drug Monitorings Market Size by Type
        9.2.1 Latin America Theraputic Drug Monitorings Market Size by Type (2016-2021)
        9.2.2 Latin America Theraputic Drug Monitorings Market Size by Type (2022-2027)
        9.2.3 Latin America Theraputic Drug Monitorings Market Size by Type (2016-2027)
    9.3 Latin America Theraputic Drug Monitorings Market Size by Application
        9.3.1 Latin America Theraputic Drug Monitorings Market Size by Application (2016-2021)
        9.3.2 Latin America Theraputic Drug Monitorings Market Size by Application (2022-2027)
        9.3.3 Latin America Theraputic Drug Monitorings Market Size by Application (2016-2027)
    9.4 Latin America Theraputic Drug Monitorings Market Size by Country
        9.4.1 Latin America Theraputic Drug Monitorings Market Size by Country (2016-2021)
        9.4.2 Latin America Theraputic Drug Monitorings Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Theraputic Drug Monitorings Market Size (2016-2027)
    10.2 Middle East & Africa Theraputic Drug Monitorings Market Size by Type
        10.2.1 Middle East & Africa Theraputic Drug Monitorings Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Theraputic Drug Monitorings Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Theraputic Drug Monitorings Market Size by Type (2016-2027)
    10.3 Middle East & Africa Theraputic Drug Monitorings Market Size by Application
        10.3.1 Middle East & Africa Theraputic Drug Monitorings Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Theraputic Drug Monitorings Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Theraputic Drug Monitorings Market Size by Application (2016-2027)
    10.4 Middle East & Africa Theraputic Drug Monitorings Market Size by Country
        10.4.1 Middle East & Africa Theraputic Drug Monitorings Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Theraputic Drug Monitorings Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Roche AG
        11.1.1 Roche AG Company Details
        11.1.2 Roche AG Business Overview
        11.1.3 Roche AG Theraputic Drug Monitorings Introduction
        11.1.4 Roche AG Revenue in Theraputic Drug Monitorings Business (2016-2021)
        11.1.5 Roche AG Recent Development
    11.2 Siemens Healthineers
        11.2.1 Siemens Healthineers Company Details
        11.2.2 Siemens Healthineers Business Overview
        11.2.3 Siemens Healthineers Theraputic Drug Monitorings Introduction
        11.2.4 Siemens Healthineers Revenue in Theraputic Drug Monitorings Business (2016-2021)
        11.2.5 Siemens Healthineers Recent Development
    11.3 Thermo Fisher Scientific
        11.3.1 Thermo Fisher Scientific Company Details
        11.3.2 Thermo Fisher Scientific Business Overview
        11.3.3 Thermo Fisher Scientific Theraputic Drug Monitorings Introduction
        11.3.4 Thermo Fisher Scientific Revenue in Theraputic Drug Monitorings Business (2016-2021)
        11.3.5 Thermo Fisher Scientific Recent Development
    11.4 Beckman Coulter
        11.4.1 Beckman Coulter Company Details
        11.4.2 Beckman Coulter Business Overview
        11.4.3 Beckman Coulter Theraputic Drug Monitorings Introduction
        11.4.4 Beckman Coulter Revenue in Theraputic Drug Monitorings Business (2016-2021)
        11.4.5 Beckman Coulter Recent Development
    11.5 Agilent Technologies
        11.5.1 Agilent Technologies Company Details
        11.5.2 Agilent Technologies Business Overview
        11.5.3 Agilent Technologies Theraputic Drug Monitorings Introduction
        11.5.4 Agilent Technologies Revenue in Theraputic Drug Monitorings Business (2016-2021)
        11.5.5 Agilent Technologies Recent Development
    11.6 BioMérieux
        11.6.1 BioMérieux Company Details
        11.6.2 BioMérieux Business Overview
        11.6.3 BioMérieux Theraputic Drug Monitorings Introduction
        11.6.4 BioMérieux Revenue in Theraputic Drug Monitorings Business (2016-2021)
        11.6.5 BioMérieux Recent Development
    11.7 Sekisui Medical
        11.7.1 Sekisui Medical Company Details
        11.7.2 Sekisui Medical Business Overview
        11.7.3 Sekisui Medical Theraputic Drug Monitorings Introduction
        11.7.4 Sekisui Medical Revenue in Theraputic Drug Monitorings Business (2016-2021)
        11.7.5 Sekisui Medical Recent Development
    11.8 DiaSorin
        11.8.1 DiaSorin Company Details
        11.8.2 DiaSorin Business Overview
        11.8.3 DiaSorin Theraputic Drug Monitorings Introduction
        11.8.4 DiaSorin Revenue in Theraputic Drug Monitorings Business (2016-2021)
        11.8.5 DiaSorin Recent Development
    11.9 Fujirebio
        11.9.1 Fujirebio Company Details
        11.9.2 Fujirebio Business Overview
        11.9.3 Fujirebio Theraputic Drug Monitorings Introduction
        11.9.4 Fujirebio Revenue in Theraputic Drug Monitorings Business (2016-2021)
        11.9.5 Fujirebio Recent Development
    11.10 Grifols
        11.10.1 Grifols Company Details
        11.10.2 Grifols Business Overview
        11.10.3 Grifols Theraputic Drug Monitorings Introduction
        11.10.4 Grifols Revenue in Theraputic Drug Monitorings Business (2016-2021)
        11.10.5 Grifols Recent Development
    11.11 Ortho-Clinical Diagnostics
        11.11.1 Ortho-Clinical Diagnostics Company Details
        11.11.2 Ortho-Clinical Diagnostics Business Overview
        11.11.3 Ortho-Clinical Diagnostics Theraputic Drug Monitorings Introduction
        11.11.4 Ortho-Clinical Diagnostics Revenue in Theraputic Drug Monitorings Business (2016-2021)
        11.11.5 Ortho-Clinical Diagnostics Recent Development
    11.12 Quest Diagnostics
        11.12.1 Quest Diagnostics Company Details
        11.12.2 Quest Diagnostics Business Overview
        11.12.3 Quest Diagnostics Theraputic Drug Monitorings Introduction
        11.12.4 Quest Diagnostics Revenue in Theraputic Drug Monitorings Business (2016-2021)
        11.12.5 Quest Diagnostics Recent Development
    11.13 Sysmex
        11.13.1 Sysmex Company Details
        11.13.2 Sysmex Business Overview
        11.13.3 Sysmex Theraputic Drug Monitorings Introduction
        11.13.4 Sysmex Revenue in Theraputic Drug Monitorings Business (2016-2021)
        11.13.5 Sysmex Recent Development
    11.14 Tosoh
        11.14.1 Tosoh Company Details
        11.14.2 Tosoh Business Overview
        11.14.3 Tosoh Theraputic Drug Monitorings Introduction
        11.14.4 Tosoh Revenue in Theraputic Drug Monitorings Business (2016-2021)
        11.14.5 Tosoh Recent Development
    11.15 Chromsystems
        11.15.1 Chromsystems Company Details
        11.15.2 Chromsystems Business Overview
        11.15.3 Chromsystems Theraputic Drug Monitorings Introduction
        11.15.4 Chromsystems Revenue in Theraputic Drug Monitorings Business (2016-2021)
        11.15.5 Chromsystems Recent Development
    11.16 Bio-Rad
        11.16.1 Bio-Rad Company Details
        11.16.2 Bio-Rad Business Overview
        11.16.3 Bio-Rad Theraputic Drug Monitorings Introduction
        11.16.4 Bio-Rad Revenue in Theraputic Drug Monitorings Business (2016-2021)
        11.16.5 Bio-Rad Recent Development
    11.17 R-Biopharm AG
        11.17.1 R-Biopharm AG Company Details
        11.17.2 R-Biopharm AG Business Overview
        11.17.3 R-Biopharm AG Theraputic Drug Monitorings Introduction
        11.17.4 R-Biopharm AG Revenue in Theraputic Drug Monitorings Business (2016-2021)
        11.17.5 R-Biopharm AG Recent Development
    11.18 ALPCO
        11.18.1 ALPCO Company Details
        11.18.2 ALPCO Business Overview
        11.18.3 ALPCO Theraputic Drug Monitorings Introduction
        11.18.4 ALPCO Revenue in Theraputic Drug Monitorings Business (2016-2021)
        11.18.5 ALPCO Recent Development
    11.18 BIOHIT Healthcare
        .1 BIOHIT Healthcare Company Details
        .2 BIOHIT Healthcare Business Overview
        .3 BIOHIT Healthcare Theraputic Drug Monitorings Introduction
        .4 BIOHIT Healthcare Revenue in Theraputic Drug Monitorings Business (2016-2021)
        .5 BIOHIT Healthcare Recent Development
    11.20 MedTox
        11.20.1 MedTox Company Details
        11.20.2 MedTox Business Overview
        11.20.3 MedTox Theraputic Drug Monitorings Introduction
        11.20.4 MedTox Revenue in Theraputic Drug Monitorings Business (2016-2021)
        11.20.5 MedTox Recent Development
    11.21 Wieslab
        11.21.1 Wieslab Company Details
        11.21.2 Wieslab Business Overview
        11.21.3 Wieslab Theraputic Drug Monitorings Introduction
        11.21.4 Wieslab Revenue in Theraputic Drug Monitorings Business (2016-2021)
        11.21.5 Wieslab Recent Development
    11.22 ARK Diagnostics
        11.22.1 ARK Diagnostics Company Details
        11.22.2 ARK Diagnostics Business Overview
        11.22.3 ARK Diagnostics Theraputic Drug Monitorings Introduction
        11.22.4 ARK Diagnostics Revenue in Theraputic Drug Monitorings Business (2016-2021)
        11.22.5 ARK Diagnostics Recent Development
    11.23 Probe Scientific
        11.23.1 Probe Scientific Company Details
        11.23.2 Probe Scientific Business Overview
        11.23.3 Probe Scientific Theraputic Drug Monitorings Introduction
        11.23.4 Probe Scientific Revenue in Theraputic Drug Monitorings Business (2016-2021)
        11.23.5 Probe Scientific Recent Development
    11.24 Omnica
        11.24.1 Omnica Company Details
        11.24.2 Omnica Business Overview
        11.24.3 Omnica Theraputic Drug Monitorings Introduction
        11.24.4 Omnica Revenue in Theraputic Drug Monitorings Business (2016-2021)
        11.24.5 Omnica Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Theraputic Drug Monitorings Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Chemiluminescence Immunoassay (CLIA)
    Table 3. Key Players of Fluorescence Immunoassay (FPIA)
    Table 4. Key Players of Radioimmunoassay (RIA)
    Table 5. Key Players of Colorimetric Immunoassay
    Table 6. Key Players of Other Immunoassays
    Table 7. Global Theraputic Drug Monitorings Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Theraputic Drug Monitorings Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Theraputic Drug Monitorings Market Size by Regions (2016-2021) & (US$ Million)
    Table 10. Global Theraputic Drug Monitorings Market Share by Regions (2016-2021)
    Table 11. Global Theraputic Drug Monitorings Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 12. Global Theraputic Drug Monitorings Market Share by Regions (2022-2027)
    Table 13. Theraputic Drug Monitorings Market Trends
    Table 14. Theraputic Drug Monitorings Market Drivers
    Table 15. Theraputic Drug Monitorings Market Challenges
    Table 16. Theraputic Drug Monitorings Market Restraints
    Table 17. Global Theraputic Drug Monitorings Revenue by Players (2016-2021) & (US$ Million)
    Table 18. Global Theraputic Drug Monitorings Market Share by Players (2016-2021)
    Table 19. Global Top Theraputic Drug Monitorings Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Theraputic Drug Monitorings as of 2020)
    Table 20. Ranking of Global Top Theraputic Drug Monitorings Companies by Revenue (US$ Million) in 2020
    Table 21. Global 5 Largest Players Market Share by Theraputic Drug Monitorings Revenue (CR5 and HHI) & (2016-2021)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Theraputic Drug Monitorings Product Solution and Service
    Table 24. Date of Enter into Theraputic Drug Monitorings Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Theraputic Drug Monitorings Market Size by Type (2016-2021) (US$ Million)
    Table 27. Global Theraputic Drug Monitorings Revenue Market Share by Type (2016-2021)
    Table 28. Global Theraputic Drug Monitorings Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 29. Global Theraputic Drug Monitorings Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 30. Global Theraputic Drug Monitorings Market Size Share by Application (2016-2021) & (US$ Million)
    Table 31. Global Theraputic Drug Monitorings Revenue Market Share by Application (2016-2021)
    Table 32. Global Theraputic Drug Monitorings Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 33. Global Theraputic Drug Monitorings Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 34. North America Theraputic Drug Monitorings Market Size by Type (2016-2021) (US$ Million)
    Table 35. North America Theraputic Drug Monitorings Market Size by Type (2022-2027) & (US$ Million)
    Table 36. North America Theraputic Drug Monitorings Market Size by Application (2016-2021) (US$ Million)
    Table 37. North America Theraputic Drug Monitorings Market Size by Application (2022-2027) & (US$ Million)
    Table 38. North America Theraputic Drug Monitorings Market Size by Country (2016-2021) & (US$ Million) 
    Table 39. North America Theraputic Drug Monitorings Market Size by Country (2022-2027) & (US$ Million) 
    Table 40. Europe Theraputic Drug Monitorings Market Size by Type (2016-2021) (US$ Million)
    Table 41. Europe Theraputic Drug Monitorings Market Size by Type (2022-2027) & (US$ Million)
    Table 42. Europe Theraputic Drug Monitorings Market Size by Application (2016-2021) (US$ Million)
    Table 43. Europe Theraputic Drug Monitorings Market Size by Application (2022-2027) & (US$ Million)
    Table 44. Europe Theraputic Drug Monitorings Market Size by Country (2016-2021) & (US$ Million) 
    Table 45. Europe Theraputic Drug Monitorings Market Size by Country (2022-2027) & (US$ Million) 
    Table 46. Asia-Pacific Theraputic Drug Monitorings Market Size by Type (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Theraputic Drug Monitorings Market Size by Type (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Theraputic Drug Monitorings Market Size by Application (2016-2021) (US$ Million)
    Table 49. Asia-Pacific Theraputic Drug Monitorings Market Size by Application (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific Theraputic Drug Monitorings Market Size by Region (2016-2021) & (US$ Million) 
    Table 51. Asia-Pacific Theraputic Drug Monitorings Market Size by Region (2022-2027) & (US$ Million) 
    Table 52. Latin America Theraputic Drug Monitorings Market Size by Type (2016-2021) (US$ Million)
    Table 53. Latin America Theraputic Drug Monitorings Market Size by Type (2022-2027) & (US$ Million)
    Table 54. Latin America Theraputic Drug Monitorings Market Size by Application (2016-2021) (US$ Million)
    Table 55. Latin America Theraputic Drug Monitorings Market Size by Application (2022-2027) & (US$ Million)
    Table 56. Latin America Theraputic Drug Monitorings Market Size by Country (2016-2021) & (US$ Million) 
    Table 57. Latin America Theraputic Drug Monitorings Market Size by Country (2022-2027) & (US$ Million) 
    Table 58. Middle East & Africa Theraputic Drug Monitorings Market Size by Type (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Theraputic Drug Monitorings Market Size by Type (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Theraputic Drug Monitorings Market Size by Application (2016-2021) (US$ Million)
    Table 61. Middle East & Africa Theraputic Drug Monitorings Market Size by Application (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa Theraputic Drug Monitorings Market Size by Country (2016-2021) & (US$ Million) 
    Table 63. Middle East & Africa Theraputic Drug Monitorings Market Size by Country (2022-2027) & (US$ Million) 
    Table 64. Roche AG Company Details
    Table 65. Roche AG Business Overview
    Table 66. Roche AG Theraputic Drug Monitorings Product
    Table 67. Roche AG Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
    Table 68. Roche AG Recent Development
    Table 69. Siemens Healthineers Company Details
    Table 70. Siemens Healthineers Business Overview
    Table 71. Siemens Healthineers Theraputic Drug Monitorings Product
    Table 72. Siemens Healthineers Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
    Table 73. Siemens Healthineers Recent Development
    Table 74. Thermo Fisher Scientific Company Details
    Table 75. Thermo Fisher Scientific Business Overview
    Table 76. Thermo Fisher Scientific Theraputic Drug Monitorings Product
    Table 77. Thermo Fisher Scientific Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
    Table 78. Thermo Fisher Scientific Recent Development
    Table 79. Beckman Coulter Company Details
    Table 80. Beckman Coulter Business Overview
    Table 81. Beckman Coulter Theraputic Drug Monitorings Product
    Table 82. Beckman Coulter Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
    Table 83. Beckman Coulter Recent Development
    Table 84. Agilent Technologies Company Details
    Table 85. Agilent Technologies Business Overview
    Table 86. Agilent Technologies Theraputic Drug Monitorings Product
    Table 87. Agilent Technologies Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
    Table 88. Agilent Technologies Recent Development
    Table 89. BioMérieux Company Details
    Table 90. BioMérieux Business Overview
    Table 91. BioMérieux Theraputic Drug Monitorings Product
    Table 92. BioMérieux Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
    Table 93. BioMérieux Recent Development
    Table 94. Sekisui Medical Company Details
    Table 95. Sekisui Medical Business Overview
    Table 96. Sekisui Medical Theraputic Drug Monitorings Product
    Table 97. Sekisui Medical Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
    Table 98. Sekisui Medical Recent Development
    Table 99. DiaSorin Company Details
    Table 100. DiaSorin Business Overview
    Table 101. DiaSorin Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
    Table 102. DiaSorin Recent Development
    Table 103. Fujirebio Company Details
    Table 104. Fujirebio Business Overview
    Table 105. Fujirebio Theraputic Drug Monitorings Product
    Table 106. Fujirebio Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
    Table 107. Fujirebio Recent Development
    Table 108. Grifols Company Details
    Table 109. Grifols Business Overview
    Table 110. Grifols Theraputic Drug Monitorings Product
    Table 111. Grifols Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
    Table 112. Grifols Recent Development
    Table 113. Ortho-Clinical Diagnostics Company Details
    Table 114. Ortho-Clinical Diagnostics Business Overview
    Table 115. Ortho-Clinical Diagnostics Theraputic Drug Monitorings Product
    Table 116. Ortho-Clinical Diagnostics Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
    Table 117. Ortho-Clinical Diagnostics Recent Development
    Table 118. Quest Diagnostics Company Details
    Table 119. Quest Diagnostics Business Overview
    Table 120. Quest Diagnostics Theraputic Drug Monitorings Product
    Table 121. Quest Diagnostics Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
    Table 122. Quest Diagnostics Recent Development
    Table 123. Sysmex Company Details
    Table 124. Sysmex Business Overview
    Table 125. Sysmex Theraputic Drug Monitorings Product
    Table 126. Sysmex Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
    Table 127. Sysmex Recent Development
    Table 128. Tosoh Company Details
    Table 129. Tosoh Business Overview
    Table 130. Tosoh Theraputic Drug Monitorings Product
    Table 131. Tosoh Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
    Table 132. Tosoh Recent Development
    Table 133. Chromsystems Company Details
    Table 134. Chromsystems Business Overview
    Table 135. Chromsystems Theraputic Drug Monitorings Product
    Table 136. Chromsystems Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
    Table 137. Chromsystems Recent Development
    Table 138. Bio-Rad Company Details
    Table 139. Bio-Rad Business Overview
    Table 140. Bio-Rad Theraputic Drug Monitorings Product
    Table 141. Bio-Rad Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
    Table 142. Bio-Rad Recent Development
    Table 143. R-Biopharm AG Company Details
    Table 144. R-Biopharm AG Business Overview
    Table 145. R-Biopharm AG Theraputic Drug Monitorings Product
    Table 146. R-Biopharm AG Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
    Table 147. R-Biopharm AG Recent Development
    Table 148. ALPCO Company Details
    Table 149. ALPCO Business Overview
    Table 150. ALPCO Theraputic Drug Monitorings Product
    Table 151. ALPCO Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
    Table 152. ALPCO Recent Development
    Table 153. BIOHIT Healthcare Company Details
    Table 154. BIOHIT Healthcare Business Overview
    Table 155. BIOHIT Healthcare Theraputic Drug Monitorings Product
    Table 156. BIOHIT Healthcare Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
    Table 157. BIOHIT Healthcare Recent Development
    Table 158. MedTox Company Details
    Table 159. MedTox Business Overview
    Table 160. MedTox Theraputic Drug Monitorings Product
    Table 161. MedTox Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
    Table 162. MedTox Recent Development
    Table 163. Wieslab Company Details
    Table 164. Wieslab Business Overview
    Table 165. Wieslab Theraputic Drug Monitorings Product
    Table 166. Wieslab Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
    Table 167. Wieslab Recent Development
    Table 168. ARK Diagnostics Company Details
    Table 169. ARK Diagnostics Business Overview
    Table 170. ARK Diagnostics Theraputic Drug Monitorings Product
    Table 171. ARK Diagnostics Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
    Table 172. ARK Diagnostics Recent Development
    Table 173. Probe Scientific Company Details
    Table 174. Probe Scientific Business Overview
    Table 175. Probe Scientific Theraputic Drug Monitorings Product
    Table 176. Probe Scientific Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
    Table 177. Probe Scientific Recent Development
    Table 178. Omnica Company Details
    Table 179. Omnica Business Overview
    Table 180. Omnica Theraputic Drug MonitoringsProduct
    Table 181. Omnica Revenue in Theraputic Drug Monitorings Business (2016-2021) & (US$ Million)
    Table 182. Omnica Recent Development
    Table 183. Research Programs/Design for This Report
    Table 184. Key Data Information from Secondary Sources
    Table 185. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Theraputic Drug Monitorings Market Share by Type: 2020 VS 2027
    Figure 2. Chemiluminescence Immunoassay (CLIA) Features
    Figure 3. Fluorescence Immunoassay (FPIA) Features
    Figure 4. Radioimmunoassay (RIA) Features
    Figure 5. Colorimetric Immunoassay Features
    Figure 6. Other Immunoassays Features
    Figure 7. Global Theraputic Drug Monitorings Market Share by Application: 2020 VS 2027
    Figure 8. Antiepileptic Drugs Case Studies
    Figure 9. Immunosuppressant Case Studies
    Figure 10. Antitumor Drugs Case Studies
    Figure 11. Psychotropic Drugs Case Studies
    Figure 12. Antibiotic Case Studies
    Figure 13. Antifungal Case Studies
    Figure 14. Cardiovascular Drugs Case Studies
    Figure 15. Antiasthmatic Case Studies
    Figure 16. Others Case Studies
    Figure 17. Theraputic Drug Monitorings Report Years Considered
    Figure 18. Global Theraputic Drug Monitorings Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 19. Global Theraputic Drug Monitorings Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 20. Global Theraputic Drug Monitorings Market Share by Regions: 2020 VS 2027
    Figure 21. Global Theraputic Drug Monitorings Market Share by Regions (2022-2027)
    Figure 22. Global Theraputic Drug Monitorings Market Share by Players in 2020
    Figure 23. Global Top Theraputic Drug Monitorings Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Theraputic Drug Monitorings as of 2020
    Figure 24. The Top 10 and 5 Players Market Share by Theraputic Drug Monitorings Revenue in 2020
    Figure 25. Global Theraputic Drug Monitorings Revenue Market Share by Type (2016-2021)
    Figure 26. Global Theraputic Drug Monitorings Revenue Market Share by Type (2022-2027)
    Figure 27. North America Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. North America Theraputic Drug Monitorings Market Share by Type (2016-2027)
    Figure 29. North America Theraputic Drug Monitorings Market Share by Application (2016-2027)
    Figure 30. North America Theraputic Drug Monitorings Market Share by Country (2016-2027)
    Figure 31. United States Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Canada Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Europe Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Europe Theraputic Drug Monitorings Market Share by Type (2016-2027)
    Figure 35. Europe Theraputic Drug Monitorings Market Share by Application (2016-2027)
    Figure 36. Europe Theraputic Drug Monitorings Market Share by Country (2016-2027)
    Figure 37. Germany Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. France Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. U.K. Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Italy Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Russia Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Nordic Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Asia-Pacific Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Asia-Pacific Theraputic Drug Monitorings Market Share by Type (2016-2027)
    Figure 45. Asia-Pacific Theraputic Drug Monitorings Market Share by Application (2016-2027)
    Figure 46. Asia-Pacific Theraputic Drug Monitorings Market Share by Region (2016-2027)
    Figure 47. China Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Japan Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. South Korea Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Southeast Asia Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. India Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Australia Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Latin America Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Latin America Theraputic Drug Monitorings Market Share by Type (2016-2027)
    Figure 55. Latin America Theraputic Drug Monitorings Market Share by Application (2016-2027)
    Figure 56. Latin America Theraputic Drug Monitorings Market Share by Country (2016-2027)
    Figure 57. Mexico Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Brazil Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Middle East & Africa Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Middle East & Africa Theraputic Drug Monitorings Market Share by Type (2016-2027)
    Figure 61. Middle East & Africa Theraputic Drug Monitorings Market Share by Application (2016-2027)
    Figure 62. Middle East & Africa Theraputic Drug Monitorings Market Share by Country (2016-2027)
    Figure 63. Turkey Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 64. Saudi Arabia Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 65. UAE Theraputic Drug Monitorings Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 66. Roche AG Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
    Figure 67. Siemens Healthineers Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
    Figure 68. Thermo Fisher Scientific Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
    Figure 69. Beckman Coulter Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
    Figure 70. Agilent Technologies Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
    Figure 71. BioMérieux Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
    Figure 72. Sekisui Medical Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
    Figure 73. DiaSorin Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
    Figure 74. Fujirebio Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
    Figure 75. Grifols Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
    Figure 76. Ortho-Clinical Diagnostics Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
    Figure 77. Quest Diagnostics Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
    Figure 78. Sysmex Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
    Figure 79. Tosoh Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
    Figure 80. Chromsystems Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
    Figure 81. Bio-Rad Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
    Figure 82. R-Biopharm AG Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
    Figure 83. ALPCO Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
    Figure 84. BIOHIT Healthcare Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
    Figure 85. MedTox Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
    Figure 86. Wieslab Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
    Figure 87. ARK Diagnostics Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
    Figure 88. Probe Scientific Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
    Figure 89. Omnica Revenue Growth Rate in Theraputic Drug Monitorings Business (2016-2021)
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche AG
Siemens Healthineers
Thermo Fisher Scientific
Beckman Coulter
Agilent Technologies
BioMérieux
Sekisui Medical
DiaSorin
Fujirebio
Grifols
Ortho-Clinical Diagnostics
Quest Diagnostics
Sysmex
Tosoh
Chromsystems
Bio-Rad
R-Biopharm AG
ALPCO
BIOHIT Healthcare
MedTox
Wieslab
ARK Diagnostics
Probe Scientific
Omnica
Frequently Asked Questions
Theraputic Drug Monitorings report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Theraputic Drug Monitorings report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Theraputic Drug Monitorings report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Wetrooms

A wet room is a totally waterproofed or tanked bathroom with a shower area at the same level as t ... Read More